science wire

« BACK

Pharmacology



Results 1 - 50 of 2777.
1 2 3 4 5 ... 56 Next »


Pharmacology - Health - 13.01.2022

Health - Pharmacology - 13.01.2022
Dramatic fall in hospital admissions for child infections since start of covid-19 pandemic
Since the onset of the covid-19 pandemic, there have been dramatic reductions in hospital admissions for common and severe childhood infections in England, most likely due to social distancing measur

Health - Pharmacology - 13.01.2022
A spray to protect against lung damage from Covid-19
A spray to protect against lung damage from Covid-19
Rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases.

Health - Pharmacology - 13.01.2022
COVID: why T cell vaccines could be the key to long-term immunity
COVID: why T cell vaccines could be the key to long-term immunity
With omicron having rapidly driven up COVID infections, attention is once again focusing on antibodies, and reasonably so.

Health - Pharmacology - 13.01.2022
UHN and University of Toronto receive $24-million federal grant for transplant research
UHN and University of Toronto receive $24-million federal grant for transplant research
Researchers at University Health Network (UHN) and the University of Toronto have received $24 million to advance technology to repair and rebuild organs outside the body for patients in need.

Pharmacology - Health - 13.01.2022
UW Pharmacy’s Drug Interaction Database, built to promote medication safety, wins national innovation award
For more than 20 years, the University of Washington has been home to a database built, maintained and expanded around the goal of helping to prevent health complications from adverse drug reactions, one of the leading causes of injury and death in health care settings.

Health - Pharmacology - 11.01.2022

Pharmacology - Health - 08.01.2022
Second generation CAR T-cell therapy trialled in patients
A new CAR T-cell therapy developed by scientists at UCL has fewer 'toxic' side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase I clinical trial of patients at University College London Hospitals (UCLH).

Health - Pharmacology - 04.01.2022
Early data for multivariant COVID-19 vaccine booster shows promise
Early data for multivariant COVID-19 vaccine booster shows promise
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.

Health - Pharmacology - 04.01.2022
UBC experts on COVID-19 pandemic
UBC experts on COVID-19 pandemic
Media Advisories UBC Media Relations UBC experts are available to comment on the COVID-19 pandemic.

Health - Pharmacology - 03.01.2022

Pharmacology - Health - 23.12.2021
Your daily medications could put you at greater risk of sunburn
Your daily medications could put you at greater risk of sunburn
With summer holidays underway, it's time to think about the sun and your skin, say researchers from the Sydney Pharmacy School.

Health - Pharmacology - 22.12.2021

Health - Pharmacology - 22.12.2021
How our experts shaped the COVID-19 response
How our experts shaped the COVID-19 response
Perhaps more than ever before, 2021 saw an increased demand for our researchers' expertise. Governments, industry, and the public were hungry for a better understanding of the COVID-19 pandemic, as well as the way forward.

Health - Pharmacology - 21.12.2021
Cancer researchers across the UK join forces to find drugs for rare cancers
Cancer researchers across the UK join forces to find drugs for rare cancers
Cancer Research UK, The University of Manchester and Roche, today (Monday 20th), announce a partnership to run a multi-drug, precision medicine platform trial for adults and children with rare cancers who have run out of other treatment options.

Health - Pharmacology - 20.12.2021
Omicron may be significantly better at evading vaccine-induced immunity, but less likely to cause severe disease
The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from Cambridge - but preliminary evidence suggests it is less likely to cause severe COVID-19 illness in the lungs. Omicron's mutations present the virus with a double-edged sword: it's got better at evading the immune system, but it might have lost some of its ability to cause severe disease Ravi Gupta As the SARS-CoV-2 virus replicates and spreads, errors in its genetic code can lead to changes in the virus.

Health - Pharmacology - 17.12.2021
UCLA gene therapy gives new life to girl born with fatal immune disorder
After more than two years, the first child to receive the innovative treatment for LAD-1 remains healthy and disease-free After more than two years, the first child to receive the innovative treatmen

Health - Pharmacology - 17.12.2021
Yale experts join campaign to boost vaccinations in communities of color
Faculty experts at Yale have partnered with Made to Save , a national campaign working to increase vaccinations in communities of color, to develop a new that helps doctors, nurses, and other health care professionals talk more effectively with patients about the COVID-19 vaccine.

Pharmacology - Health - 16.12.2021
Needs of patients with opioid use disorder similar to other patients
With the magnitude of the opioid crisis, there has been a growing call for treatment of patients with opioid use disorder to be expanded beyond specialist care and into the hands of primary care physicians. Yet while primary care providers are positioned to offer these services - and are already allowed to prescribe buprenorphine and naloxone treatment - many choose not to, citing a lack of institutional support and discomfort managing the more complex medical needs sometimes associated with this disorder.

Pharmacology - Health - 15.12.2021
TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections.

Pharmacology - 15.12.2021
Childhood trauma linked to psychotic symptoms in young cannabis users
Childhood trauma may increase the chance of young people experiencing psychotic symptoms when using cannabis, University of Queensland research has found.

Pharmacology - Social Sciences - 15.12.2021
Teen use of illicit drugs decreased in 2021, as the COVID-19 pandemic continued
Declines in adolescent use of illicit drugs reported in 2021 were the largest and most sweeping ever recorded in the past 46 years, according to the Monitoring the Future study.

Health - Pharmacology - 14.12.2021
Q and A with the experts: COVID-19 variants
Many people will need a third dose of the vaccine to protect against Omicron. Omicron is the latest COVID-19 variant of concern, and it is expected to change the course of the pandemic.

Health - Pharmacology - 14.12.2021
A medication against SARS-CoV-2
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide partnership. But mediacations against Covid-19 have as yet seen only partial success. With the support of the Bavarian Research Foundation, a Munich research team has developed a protein which has reliably prevented infection by the virus and its variants in cell tests.

Pharmacology - Health - 14.12.2021
Opinion: The richest countries are vaccine hoarders. Try them in international court
Opinion: The richest countries are vaccine hoarders. Try them in international court
Millions have died unnecessarily of Covid and millions more will in 2022 unless something changes. Justice must be done says Professor Anthony Costello (UCL Institute for Global Health).

Health - Pharmacology - 10.12.2021
RECOVERY Trial launches in South Africa
The world's largest clinical trial investigating treatments for COVID-19 has now launched in South Africa, with the first patient recruited today.

Health - Pharmacology - 09.12.2021
Two-year follow up shows delaying umbilical cord clamping saves babies' lives
Two-year follow up shows delaying umbilical cord clamping saves babies’ lives
An Australian-led study finds that aiming to wait just 60 seconds to clamp the umbilical cord of very premature babies at birth continues to have benefits two years on - decreasing the child's risk of death or major disability.

Health - Pharmacology - 09.12.2021
First UK trial to assess use of antivirals to treat COVID-19 set to be begin
The first clinical trial in the UK to investigate whether antiviral drugs could help reduce the severity of COVID-19 is due to start.

Health - Pharmacology - 09.12.2021
Important message for students about new COVID-19 safety guidance
Important message for students about new COVID-19 safety guidance
An update following the Prime Minister's announcement on 8 December of new Plan B safety measures.

Health - Pharmacology - 09.12.2021
How SARS-Cov-2 is changed by antiviral treatments focus of new UCL study
How SARS-Cov-2 is changed by antiviral treatments focus of new UCL study
Scientists at UCL will sequence the DNA of more than 10,000 samples of the SARS-CoV-2 virus to see if or how its genome is changed by different antiviral Covid-19 treatments.

Health - Pharmacology - 08.12.2021
Rapid therapeutic approaches against viral diseases
Rapid therapeutic approaches against viral diseases
Research team with new development pipeline for RNA-based drugs successful in Europe-wide competition 08.12.2021 Viruses are a major problem for human health worldwide - and not just since the outbreak of the SARS-CoV2 pandemic. Despite successful vaccine development, there are still no effective drugs for most viral diseases.
1 2 3 4 5 ... 56 Next »